T
MRNA icon

Tidemark’s Moderna MRNA Stock Holding History

Tidemark’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280 Buy
+4
New +$207 ﹤0.01% 885
2024
Q3 		– Sell
-127
Closed -$15.1K – 636
2024
Q2 		$15.1K Hold
127
– – 0.01% 363
2024
Q1 		$13.5K Sell
127
-19
-13% -$1.92K 0.01% 393
2023
Q4 		$14.5K Buy
+146
New +$12.3K 0.01% 377

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Tidemark's MRNA Position: Q2 2026 in Review

Tidemark opened a new position in Moderna (MRNA) in Q2 2026: 4 shares worth $280. The stake represents ﹤0.01% of the portfolio and ranks #885 among its holdings. This is a return to the name: Tidemark previously reported a position in MRNA as recently as Q2 2024.

Tidemark first reported a position in MRNA in Q4 2023 and has held it in 4 quarters since. The position peaked at $15.1K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Tidemark held 4 shares of Moderna worth $280 as of Q2 2026.
  • Moderna was a new Tidemark position in Q2 2026.
  • Moderna made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #885 holding.
  • Tidemark first reported a position in Moderna in Q4 2023 and has held it in 4 quarters since.
  • Tidemark's Moderna position peaked at $15.1K in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.